Project owner's name :
Mr Noah Charles Benedict
Mr Noah Charles Benedict
Country of deployment for the project :
Sierra Leone
Sierra Leone
Sector :
Health
Health
What problem does your company want to solve? :
Delay of shipment and scarcity of antisera because of increasing demand Increase in maternal mortality rate Infant mortality among under-five’s
Delay of shipment and scarcity of antisera because of increasing demand Increase in maternal mortality rate Infant mortality among under-five’s
What solution does your company provide? :
It improves the socio-economic status of Sierra Leoneans thereby reducing the economic burden it places on the nation’s budget Helps to improve quality of clinical care Makes blood typing easier and
It improves the socio-economic status of Sierra Leoneans thereby reducing the economic burden it places on the nation’s budget Helps to improve quality of clinical care Makes blood typing easier and
Describe your project :
UNIMAK Haema Antiserum is a monoclonal agglutination serum used for the determination of human blood typing groups (ABO) in Sierra Leone. It is useful for blood grouping especially before blood transfusion, clinical care, and treatments for cancer patients, and also relevant for surgical procedures
UNIMAK Haema Antiserum is a monoclonal agglutination serum used for the determination of human blood typing groups (ABO) in Sierra Leone. It is useful for blood grouping especially before blood transfusion, clinical care, and treatments for cancer patients, and also relevant for surgical procedures